Related Experiment Videos
SELDI ProteinChip(R) Array Technology: Protein-Based Predictive Medicine and Drug Discovery Applications
Journal of Biomedicine & Biotechnology
|November 15, 2003
Summary
Predictive medicine advances using ProteinChip Array technology for disease detection and treatment. This approach identifies novel biomarkers for improved patient prognosis and drug development, enhancing personalized healthcare strategies.
Area of Science:
- Biotechnology
- Proteomics
- Translational Medicine
Background:
- Predictive medicine aims to forecast disease onset and progression.
- Novel biomarkers are crucial for early disease detection and personalized treatment.
- ProteinChip Array technology offers a platform for high-throughput proteomic analysis.
Purpose of the Study:
- To review the applications of ProteinChip Array technology in predictive medicine.
- To highlight the role of novel biomarkers and multimarker patterns.
- To explore biomarker and drug discovery for various diseases.
Main Methods:
- Utilizing ProteinChip Array technology for biomarker discovery.
- Performing serum and tissue proteome analysis.
- Developing protein-based assays for drug discovery and mode of action studies.
Main Results:
- Identification of novel inhibitors for HIV-1 replication.
- Discovery of multimarker assays for various cancers (prostate, breast, ovarian).
- Biomarker and drug discovery applications for neurological disorders.
Conclusions:
- ProteinChip Array technology is pivotal for advancing predictive medicine.
- The technology facilitates the identification of novel biomarkers for disease detection, prognosis, and treatment monitoring.
- It supports both small molecule and protein-based drug discovery and development.